Full US approval for Pfizer vaccine expected by early September: Report | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 25, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 25, 2025
Full US approval for Pfizer vaccine expected by early September: Report

Coronavirus chronicle

BSS/AFP
04 August, 2021, 11:45 am
Last modified: 04 August, 2021, 11:50 am

Related News

  • FDA approves first menthol e-cigarettes
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose
  • US donates 10 million more Pfizer Covid shots to Bangladesh
  • US donates another 1.5m pfizer vaccines for children

Full US approval for Pfizer vaccine expected by early September: Report

The vaccine is currently being administered via an emergency use authorization that was granted in December

BSS/AFP
04 August, 2021, 11:45 am
Last modified: 04 August, 2021, 11:50 am
Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration

The U.S. Food and Drug Administration is set to fully approve the Pfizer/BioNTech Covid-19 vaccine by early next month, the New York Times reported Tuesday.

The Food and Drug Administration has set an "unofficial deadline" of the September 6 Labor Day holiday "or sooner" to give the anti-Covid shot the final green light, the newspaper reported, citing sources familiar with the plan.

The vaccine is currently being administered via an emergency use authorization that was granted in December.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The FDA had said in a statement last week that granting the Pfizer vaccine final approval was one of the agency's highest priorities and anticipated being finished with the final review soon.

Full approval could boost vaccine-hesitant Americans' confidence in getting the shot as the ultra-contagious Delta variant sweeps through the country, driving daily case counts to levels not seen since the winter.

As of August 2, the United States had seen an average of 84,389 new cases daily over the previous seven days, according to the Centers for Disease Control and Prevention.

Some 192 million Americans have already received at least one dose of one of the three Covid vaccines available in the United States -- 58 percent of the total population.

Pfizer is the most widely administered shot in the US, followed by another two-dose mRNA shot from Moderna, which is also allowed under an emergency use authorization and is seeking full approval from the FDA, which is expected to come after Pfizer's.

The one-dose shot from Johnson & Johnson is the third and least popular Covid vaccine available in the United States. It has not yet sought full FDA approval, according to the Times.

Top News

Pfizer coronavirus vaccine / Pfizer COVID vaccine / Pfizer Covid-19 Vaccine / Pfizer-BioNTech coronavirus vaccine / Pfizer-BioNTech vaccine / US Food and Drug Administration (FDA)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographics: TBS
    Inflated rents, ghost floors, Tk220cr advance: How Premier Bank funds lined Iqbal family’s pocket
  • Ahsan H Mansur. TBS sketch
    True ownership of S Alam loans, shares under fake names to be proven thru state witnesses: BB governor
  • Infographics: TBS
    Underfilled departments at DU reveal cracks in admission, academic planning

MOST VIEWED

  • Representational image/Reuters
    Dollar gets upward push as BB buys $10m more in auction at even higher rate
  •  ABM Khairul Haque. File Photo: Collected
    Former chief justice Khairul Haque detained
  • File photo of Bangladesh Bank. Photo: TBS
    Governor Mansur orders withdrawal of BB dress code after directive draws criticism
  • Representational image. Photo: Collected
    Tariff talks: Bangladesh, US set for crucial virtual meeting on 29 July
  • Mehreen Ahmed speaking to media on 11 July 2025. Photo: Collected
    Court disposes of Dhaka girl's case against parents seeking 'protection from abuse'
  • Hasina and Taposh in an event in 2020. Photo: Collected
    Al Jazeera investigation: Hasina, in call with Taposh, talks using helicopter to shoot, crush protesters in July uprising

Related News

  • FDA approves first menthol e-cigarettes
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose
  • US donates 10 million more Pfizer Covid shots to Bangladesh
  • US donates another 1.5m pfizer vaccines for children

Features

Illustration: TBS

The future of medicine: How innovations will catalyse quantum leaps in healthcare

10h | The Big Picture
Photo: Collected

24 July: More than 1400 arrested, 3 missing coordinators found

1d | Panorama
Photo: Mehedi Hasan/TBS

Aggrieved nation left with questions as citizens rally to help at burn institute

2d | Panorama
Photo: Mehedi Hasan/TBS

Mourning turns into outrage as Milestone students seek truth and justice

2d | Panorama

More Videos from TBS

There are many more examples of trials of Chief Justices in the world.

There are many more examples of trials of Chief Justices in the world.

8h | TBS Today
Why is there a massive conflict between Thailand and Cambodia?

Why is there a massive conflict between Thailand and Cambodia?

8h | TBS News Updates
Former Chief Justice ABM Khairul Haque in prison

Former Chief Justice ABM Khairul Haque in prison

9h | TBS Today
The Nvidia Chip Deal Trades Away the United States’ AI Advantage

The Nvidia Chip Deal Trades Away the United States’ AI Advantage

9h | Videos
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net